Evidence map›Paper›PMID 26313144›Full record

ArticlePloS one2015

A Linear Mixed Model Spline Framework for Analysing Time Course 'Omics' Data.

Jasmin Straube, Alain-Dominique Gorse, PROOF Centre of Excellence Team, Bevan Emma Huang, Kim-Anh Lê Cao

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Longitudinal omics data analysis: approaches and applications.Computational and structural biotechnology journal · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Serial Sampling of the Small Airway Epithelium to Identify Persistent Smoking-dysregulated Genes.American journal of respiratory and critical care medicine · 2023
    Article
  14. Article
  15. Phosphoproteomics data-driven signalling network inference: Does it work?Computational and structural biotechnology journal · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jasmin StraubeQFAB Bioinformatics, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia; The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia.
Alain-Dominique GorseQFAB Bioinformatics, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia.
PROOF Centre of Excellence Team
Bevan Emma HuangCSIRO Digital Productivity Flagship, Brisbane, QLD, Australia.
Kim-Anh Lê CaoThe University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Time course 'omics' experiments are becoming increasingly important to study system-wide dynamic regulation. Despite their high information content, analysis remains challenging. 'Omics' technologies capture quantitative measurements on tens of thousands of molecules. Therefore, in a time course 'omics' experiment molecules are measured for multiple subjects over multiple time points. This results in a large, high-dimensional dataset, which requires computationally efficient approaches for statistical analysis. Moreover, methods need to be able to handle missing values and various levels of noise. We present a novel, robust and powerful framework to analyze time course 'omics' data that consists of three stages: quality assessment and filtering, profile modelling, and analysis. The first step consists of removing molecules for which expression or abundance is highly variable over time. The second step models each molecular expression profile in a linear mixed model framework which takes into account subject-specific variability. The best model is selected through a serial model selection approach and results in dimension reduction of the time course data. The final step includes two types of analysis of the modelled trajectories, namely, clustering analysis to identify groups of correlated profiles over time, and differential expression analysis to identify profiles which differ over time and/or between treatment groups. Through simulation studies we demonstrate the high sensitivity and specificity of our approach for differential expression analysis. We then illustrate how our framework can bring novel insights on two time course 'omics' studies in breast cancer and kidney rejection. The methods are publicly available, implemented in the R CRAN package lmms.

Indexed as

AllograftsAnimalsAntineoplastic AgentsBiomarkersBone MarrowBreast NeoplasmsCluster AnalysisComputer SimulationData Interpretation, StatisticalFemaleGene Expression Regulation, FungalGene Expression Regulation, NeoplasticGenomicsGraft RejectionHumansKidney TransplantationAntineoplastic AgentsBiomarkersProteins

Identifiers

PMID26313144
PMCPMC4551847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.